• Promote the Congress to your national and international network of colleagues;
  • Develop relationships with affiliated groups or organisations in your country/region;
  • Develop relationships with affiliated groups or organisations in your country/region;
  • Raise awareness and support for the Congress;
  • Contribute to the development of an exceptional scientific program for the Congress.

Darrell S. Rigel, MD MS is a Clinical Professor of Dermatology at New York University Medical Center. He is a graduate of MIT with a BS in Management Information Sciences, an MS (MBA) from the Sloan School of Management at MIT and received his MD from George Washington University. He attended Cornell University Medical Center for Internship in Internal Medicine and completed his training at NYU where he was Resident, Chief Resident, NIH Training Fellow and Dermatology Surgery Fellow. Dr. Rigel has delivered over 900 presentations at medical and governmental policy conferences worldwide and has chaired numerous national and international conferences and symposia. He is the author of numerous articles and abstracts in professional journals as well as lead editor of Cancer of the Skin, the major textbook in this field and has testified before Congress and the FDA on related issues. He often appears on National television including CNN, ABC, FOX, NBC and CBS and his research and opinions are regularly cited in the New York Times, Wall Street Journal and many other national magazines and newspapers. Dr. Rigel works with many professional and charitable organizations related to his research interests. He served as President of the American Academy of Dermatology and the American Academy of Dermatology Association and also served for 9 years as a Director of the American Board of Dermatology. He is also a Past President of the American Society for Dermatologic Surgery and the American Dermatological Association and is the current Chair of SkinPAC (the American Academy of Dermatology Association’s political action committee). He is active in the MIT alumni program serving as a Regional Chair of the MIT Educational Counselor program. Dr. Rigel has also received numerous awards and honors including the prestigious American Academy of Dermatology’s Gold Medal – the highest award in the specialty in recognition of a lifetime of achievement, the George B. Morgan Award from MIT recognizing exceptional achievement by an alumnus and the Humanitarian Award of the Melanoma Research Foundation. He has also received the American Cancer Society’s National Honor Citation for Skin Cancer Programs and multiple Presidential Citations from the Academy and American Society for Dermatologic Surgery for public education programs in skin cancer. In addition, Dr. Rigel maintains a private practice in Manhattan where he specializes in skin cancer, sun damage and aging problems of the skin and also lives in Vail, Colorado where he enjoys skiing, golf and fly fishing.

Deborah S. Sarnoff, M.D., F.A.A.D., F.A.C.P. 
Board-certified dermatologist Dr. Deborah Sarnoff is the Director of Dermatology at Cosmetique Dermatology, Laser & Plastic Surgery, LLP, New York (with offices on Park Avenue in Manhattan and on Long Island’s Gold Coast), where she specializes in cosmetic dermatology, dermatologic and laser surgery, and Mohs micrographic surgery for the treatment of skin cancer.   Dr. Sarnoff has been a Mohs surgeon for over 30 years and has performed 30,000 cases.

A Clinical Professor of Dermatology at New York University’s School of Medicine, Dr. Sarnoff graduated Summa Cum Laude with a Bachelor of Arts degree from Cornell University, where she was elected to Phi Beta Kappa.   She received her medical degree, with distinction, from the George Washington University Medical School, where she was elected to the Medical Honor Society, Alpha Omega Alpha.  Dr. Sarnoff completed her residency in dermatology and fellowship in Mohs surgery at New York University School of Medicine.  She is a Diplomate of the American Board of Dermatology and a Fellow of the American Academy of Dermatology, American College of Mohs Surgery, The American Society of Dermatologic Surgery and the American Society for Laser Medicine & Surgery.  Dr. Sarnoff is the proud recipient of the Presidential Citation Award from the American Academy of Dermatology and the Humanitarian Award from CancerCare.

Professor John Hawk BSc MD FRCP FRACP Hon FACD is Emeritus Professor and recent Head for twenty-five years of the Photobiology Department, St John’s Institute of Dermatology, Guy’s and St Thomas’ Hospitals and King’s College, London, having qualified in medicine at Otago University, Dunedin, New Zealand, then worked in general practice in Sydney, Australia, before training in dermatology at St Mary’s and Guy’s Hospitals, and the St John’s Institute of Dermatology, London, and at Harvard Medical School, Boston, USA. He has written hundreds of scientific papers, book chapters and books, was formerly editor of the journal, Clinical and Experimental Dermatology, and lectures extensively by invitation worldwide. He importantly initiated the campaign in England counselling care in the sun and with sunbeds in the 1980s and frequently appeared then and still does in all forms of the public media, serving too for many years as British Association of Dermatologists’ Press Liaison Officer. He was a founder in 1988 of the British Photodermatology Group and then its president, and a founding member of the American Photomedicine Society. He was also until recently President of the European Society for Photodermatology, of which he was again a founder member, and is now an Honorary Life Member. He is a member of the politically influential American Dermatological Association and similar European Dermatology Forum, a former Deputy President and Scientific Committee Chairman of the 2005 London European Academy of Dermatology and Venereology (EADV) Congress, a Past President of the Scientific Committee of the EADV and a regular adviser to UK statutory and government committees, to include recently a National Institute for Health and Care Excellence (NICE) committee on the advantages and disadvantages of sunlight exposure. He was also Congress President of the World Congress on Cancers of the Skin in Edinburgh, Scotland in September 2014, and was recently elected to an Honorary Fellowship of the Australasian College of Dermatologists. Finally, he has many sporting and cultural interests, and speaks excellent French and German

Professor Richard Scolyer is Co-Medical Director of Melanoma Institute Australia; He is also Senior Staff Specialist, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney; and Clinical Professor, The University of Sydney. Professor Scolyer studied medicine at the University of Tasmania. After completing clinical training in Australia and overseas, he undertook pathology training at the Canberra Hospital and at the Royal Prince Alfred Hospital leading to Fellowship of the Royal College of Pathologists of Australasia. Professor Scolyer has presented on more than 250 occasions at conferences throughout the world and is a co-author of more than 500 articles and book chapters on melanocytic pathology and related research including publications in New England Journal of Medicine, Lancet, Nature, Nature Genetics, Lancet Oncology, Journal of Clinical Oncology and Cancer Discovery. In 2006, Professor Scolyer was awarded the degree of Doctor of Medicine by The University of Sydney for his thesis of publications on melanocytic pathology. He received a NSW Premier’s Award for Outstanding Cancer Research in 2009 and 2012, and the Thomson Reuters 2015 Citation Award in the Clinical Medicine category. In 2016, Professor Scolyer was appointed editor of the 4th Edition of the World Health Organisation Classification of Tumours Skin Tumours volume. He is also Vice Chair of the Melanoma Expert Panel of the American Joint Committee on Cancer (AJCC) for the 8th edition of the AJCC Cancer Staging System, Co-lead of the Australian Melanoma Genome Project, an editorial board member of the American Journal of Surgical Pathology, Melanoma Research and Melanoma Management, a member of the International Editorial Advisory Board of Histopathology and Senior Associate Editor of Pathology. Professor Scolyer is Immediate Past President of the Australasian Division of the International Academy of Pathology. Together with other MIA colleagues, Professor Scolyer is chief investigator on a 5-year NHMRC program grant and has a personal Fellowship from the NHMRC.